Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Approved for use in oncology care according to FDA-approved indications.
HER2-overexpressing Breast Cancer, metastatic Gastric Cancer, and gastroesophageal junction adenocarcinoma.
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Mantle Cell Lymphoma, Waldenström's Macroglobulinemia.
Prevention and treatment of chemotherapy-induced febrile neutropenia and hematopoietic recovery.
Deleterious BRCA-mutated or HRD-positive Ovarian, Breast, Pancreatic, and Prostate Cancers.
BRAF V600E/K mutation-positive Melanoma, Non-Small Cell Lung Cancer, Anaplastic Thyroid Cancer, and Colorectal Cancer.
Relapsed/refractory Multiple Myeloma, Diffuse Large B-Cell Lymphoma, Small Cell Lung Cancer, or Acute Lymphoblastic Leukemia.
Approved for use in oncology care according to FDA-approved indications.
Targeted treatment of solid tumors and hematologic malignancies.
Prevention and treatment of chemotherapy-induced febrile neutropenia and hematopoietic recovery.
HER2-overexpressing Breast Cancer, metastatic Gastric Cancer, and gastroesophageal junction adenocarcinoma.
Prevention and management of chemotherapy-related organ toxicities and complications.